{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Conformationally rigid bicyclic and adamantane derivatives useful as .alpha.2-adrenergic blocking agents", "item": "https://www.patentleaderboard.com/patent/6319935"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conformationally rigid bicyclic and adamantane derivatives useful as .alpha.2-adrenergic blocking agents

Conformationally rigid bicyclic and adamantane derivatives useful as .alpha.2-adrenergic blocking agents

US Patent 6319935 · Granted Nov 20, 2001

Estimated economic value: $18,763,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of diagnosing and treating dry eye syndrome and compositions for treatin2025
Methods of diagnosing and treating dry eye syndrome and compositions for treatin2024
Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced to2023
Methods of diagnosing and treating dry eye syndrome and compositions for treatin2023
Phenyl urea derivatives as N-formyl peptide receptor modulators2022
Phenyl urea derivatives as n-formyl peptide receptor modulators2021
Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced t2021
Sulfur derivatives as chemokine receptor modulators2021
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor l2021
Imidazole derivatives as formyl peptide receptor modulators2020
Biodegradable drug delivery systems for the sustained release of proteins2020
Method for treating atrophic age related macular degeneration2019